Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negrin

Showing results (81-90 of 260) with videos related to

Pageof 26
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cellsMobin Karimi, Thai M Cao, Jeanette A Baker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cellsIrina Fernandez, Robert Zeiser, Holger Karsunky, et al.
Plos One|January 30, 2014
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantationEmanuela I Sega, Dennis B Leveson-Gower, Mareike Florek, et al.
Blood|October 24, 2002
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imagingMatthias Edinger, Yu-An Cao, Michael R Verneris, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Noninvasive assessment of tumor cell proliferation in animal modelsM Edinger, T J Sweeney, A A Tucker, et al.
Blood|January 4, 2003
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantationHeather G Shilling, Karina L McQueen, Nathalie W Cheng, et al.
Blood|March 22, 2015
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethalityDominik Schneidawind, Jeanette Baker, Antonio Pierini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphomaS J Horning, R S Negrin, J C Chao, et al.
Bone Marrow Transplantation|January 1, 1994
Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantationK G Blume, G D Long, R S Negrin, et al.
Leukemia|October 1, 1993
The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrowJ R Schriber, R S Negrin, N J Chao, et al.
Pageof 26

Showing results (81-90 of 260) with videos related to

Sort By:
Pageof 26
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cellsMobin Karimi, Thai M Cao, Jeanette A Baker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cellsIrina Fernandez, Robert Zeiser, Holger Karsunky, et al.
Plos One|January 30, 2014
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantationEmanuela I Sega, Dennis B Leveson-Gower, Mareike Florek, et al.
Blood|October 24, 2002
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imagingMatthias Edinger, Yu-An Cao, Michael R Verneris, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Noninvasive assessment of tumor cell proliferation in animal modelsM Edinger, T J Sweeney, A A Tucker, et al.
Blood|January 4, 2003
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantationHeather G Shilling, Karina L McQueen, Nathalie W Cheng, et al.
Blood|March 22, 2015
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethalityDominik Schneidawind, Jeanette Baker, Antonio Pierini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphomaS J Horning, R S Negrin, J C Chao, et al.
Bone Marrow Transplantation|January 1, 1994
Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantationK G Blume, G D Long, R S Negrin, et al.
Leukemia|October 1, 1993
The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrowJ R Schriber, R S Negrin, N J Chao, et al.
Pageof 26